cytokine;unit;maingroup;subgroup;value.mean;value.sd;condition;condition.severity;n;age.median;age.percentile.0;age.percentile.100;ga.weeks.median;ga.weeks.percentile.0;ga.weeks.percentile.100;parity.median;parity.percentile.0;parity.percentile.100;gabirth.weeks.median;gabirth.weeks.percentile.0;gabirth.weeks.percentile.100;birthweight.median;birthweight.percentile.0;birthweight.percentile.100;bmi.baseline.median;bmi.baseline.percentile.0;bmi.baseline.percentile.100;systolic.median;systolic.percentile.0;systolic.percentile.100;diastolic.median;diastolic.percentile.0;diastolic.percentile.100;pH.umbilical_artery.median;pH.umbilical_artery.percentile.0;pH.umbilical_artery.percentile.100;method
bFGF;umol/L;1;;0;0;not pregnant;;46;;;;;;;;;;;;;;;;;;;;;;;;;;;;"Human Basic FGF Immunoassay (Quantikine; R&D Systems, Inc. Minneapolis, MN)."
bFGF;umol/L;2;;2.6;6.3;healthy;;46;29;21;38;33;23;40;0;0;3;38;34;41;3350;2836;4340;22.4;18.5;29.1;116;100;135;70;60;80;7.24;7.11;7.38;"Human Basic FGF Immunoassay (Quantikine; R&D Systems, Inc. Minneapolis, MN)."
bFGF;umol/L;3;;6.8;13.8;pregnancy-induced hypertension;;46;27;23;34;34;23;37;0;0;4;37;26;40;2875;1006;4600;25.3;19.9;34.2;160;125;220;98;90;140;7.21;7.01;7.4;"Human Basic FGF Immunoassay (Quantikine; R&D Systems, Inc. Minneapolis, MN)."
bFGF;umol/L;;1;4.4;10.6;pregnancy-induced hypertension;severe;27;;;;;;;;;;;;;;;;;;;;;;;;;;;;"Human Basic FGF Immunoassay (Quantikine; R&D Systems, Inc. Minneapolis, MN)."
bFGF;umol/L;;1;9.5;17.3;pregnancy-induced hypertension;mild;19;;;;;;;;;;;;;;;;;;;;;;;;;;;;"Human Basic FGF Immunoassay (Quantikine; R&D Systems, Inc. Minneapolis, MN)."
